[1]Chen XC, Zhang MX, Liao MF, et al. Reduced Th17 response in patients with tuberculosis correlates with IL-6R expression on CD4+T cells. Am J Respir Crit Care Med, 2010,181(7):734-742. [2]Taype CA, Shamsuzzaman S, Accinelli RA, et al. Genetic susceptibility to different clinical forms of tuberculosis in the Peruvian population. Infect Genet Evol, 2010,10(4):495-504. [3]Law WS, Yew WW, Chiu Leung C, et al. Risk factors for multidrug-resistant tuberculosis in Hong Kong. Int J Tuberc Lung Dis, 2008,12(9):1065-1070. [4]Fiorenza G, Rateni L, Farroni MA, et al. TNF-alpha, TGF-beta and NO relationship in sera from tuberculosis (TB) patients of different severity. Immunol Lett, 2005,98(1):45-48.[5]Broekelmann TJ, Limper AH, Colby TV, et al. Transforming growth factor beta 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc Natl Acad Sci U S A, 1991,88(15):6642-6646. [6]Amirzargar AA, Rezaei N, Jabbari H, et al. Cytokine single nucleotide polymorphisms in Iranian patients with pulmonary tuberculosis. Eur Cytokine Netw, 2006,17(2):84-89. [7]Deng HB, Jiang CQ, Tomlinson B, et al. A polymorphism in transforming growth factor-β1 is associated with carotid plaques and increased carotid intimamedia thickness in older Chinese men: the Guangzhou Biobank Cohort Study Cardiovascular Disease Subcohort. Atherosclerosis, 2011,214(2):391-396. [8]Anestad G, Hoel T, Scheel O, et al. Atherosclerosis and tuberculosis: are they both chronic infectious diseases? Scand J Infect Dis, 2001,33(10):797. [9]中华医学会结核病学分会. 肺结核诊断和治疗指南. 中华结核和呼吸杂志, 2001,24(2):70-74.[10]李成涛, 林源, 柳燕, 等. 实时DNA定量技术的应用研究. 中国司法鉴定, 2007,(3):28-30.[11]Zhang G, Zhou B, Wang W, et al. A functional single-nucleotide polymorphism in the promoter of the gene encoding interleukin 6 is associated with susceptibility to tuberculosis. J Infect Dis, 2012,205(11):1697-1704. [12]Flynn JL, Chan J. Immunology of tuberculosis. Annu Rev Immunol, 2001,19:93-129. [13]Chamberlain J. Transforming growth factor-beta: a promising target for anti-stenosis therapy. Cardiovasc Drug Rev, 2001,19(4):329-344.[14]沈永泉, 李在连. 转化生长因子β:参与结核病致病的免疫分子. 中华结核和呼吸杂志, 2000,23(3):181-182.[15]Hirsch CS, Yoneda T, Averill L, et al. Enhancement of intracellular growth of Mycobacterium tuberculosis in human monocytes by transforming growth factor-beta 1. J Infect Dis, 1994,170(5):1229-1237. [16]Rosas-Taraco AG, Higgins DM, Sánchez-Campillo J, et al. Local pulmonary immunotherapy with siRNA targeting TGF β1 enhances antimicrobial capacity in Mycobacterium tuberculosis infected mice. Tuberculosis (Edinb), 2011,91(1):98-106. [17]Ito M, Hanaoka M, Droma Y, et al. The association of transforming growth factor beta 1 gene polymorphisms with the emphysema phenotype of COPD in Japanese. Intern Med, 2008,47(15):1387-1394. [18]Li Q, Li L, Liu Y, et al. Biological functions of Mycobacterium tuberculosis specific CD4+T cells were impaired by tuberculosis pleural fluid. Immunol Lett, 2011,138(2):113-121. [19]International HapMap Consortium. The International HapMap Project. Nature, 2003,426(6968):789-796.[20]Zha Y, Leung KH, Lo KK, et al. TGF β1 as a susceptibility gene for high myopia: a replication study with new findings. Arch Ophthalmol, 2009,127(4):541-548. [21]Fuku N, Mori S, Murakami H, et al. Association of 29C>T polymorphism in the transforming growth factorβ1 gene with lean body mass in community-dwelling Japanese population. Geriatr Gerontol Int, 2012,12(2):292-297. |